Avience Biomedicals Ltd. O IPO

listed · NSE SME · Bookbuilding IPO

Avience Biomedicals Ltd. O IPO was a ₹30.24 crore book-built issue on NSE SME with a price band of ₹196–₹208 per share, open for bidding from 18 Jun 2026 to 18 Jun 2026.

Last updated: · How we collect data

Company overview

Website
https://avienbio.com/

IPO overview

Avience Biomedicals Ltd. O raised ₹30.24 crore through a book-built issue, made up entirely of new shares, so the proceeds go to the company.

Bids were accepted within a price band of ₹196–₹208 per share (face value ₹10); the final issue price is set within this band after bidding closes.

Applications were made in lots of 600 shares, so one lot costs ₹1,24,800 at the upper end of the price band.

The shares listed on NSE SME on 25 Jun 2026.

IPO Merchant Banker was the book-running lead manager.

Promoters held 87.89% of the company before the issue.

Issue type
Bookbuilding IPO
Issue structure
Fresh capital only
Issue size
₹30.24 crore
Price
₹196–₹208 per share
Lot size
600 shares
Minimum investment (1 lot)
₹1,24,800
Face value
₹10 per share
Exchange
NSE SME
Lead manager
IPO Merchant Banker

IPO timeline

  1. Bidding opens 18 Jun 2026
  2. Bidding closes 18 Jun 2026
  3. Basis of allotment —
  4. Refunds / unblocking —
  5. Shares credited to demat —
  6. Listing 25 Jun 2026

Bidding ran from 18 Jun 2026 to 18 Jun 2026.

The shares listed on 25 Jun 2026.

Subscription summary

By the close of bidding, the issue was subscribed 385.32× overall (last figure recorded 18 Jun 2026).

A full category-wise breakdown is not available for this figure, so only the overall multiple is shown.

Bids were received for 385.32× the shares available, so not every applicant in an oversubscribed category will receive shares.

Grey market premium (unofficial)

The last grey market premium (GMP) we recorded for this issue was ₹107 on 24 Jun 2026, equal to 51.4% of the upper price band.

We do not yet record actual listing prices, so this page does not compare the GMP with where the shares opened.

  • GMP is unofficial: it is not published or verified by NSE, BSE or SEBI, changes quickly, and is not a forecast or guarantee of the listing price.

Sources and data methodology

NSE & BSE public-issue data; Chittorgarh and InvestorGain (fill gaps only); InvestorGain live subscription report (third-party); InvestorGain grey market report (unofficial). Methodology · Report an error

Tools

IPOs around the same time

In the news

Related guides